About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT06190210

Predictive Value of Neurovascular Coupling in Infants With COngenital Heart Disease

Infants with congenital heart disease (CHD) are at increased risk for delayed neurodevelopment. Multiple etiological explanations have been proposed, as there seems to be a multifactorial interplay of...

Lead sponsor: Universitaire Ziekenhuizen KU Leuven•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Liselotte Van Loo, MD

CONTACT

+3216346057 liselotte.vanloo@uzleuven.be

Sponsors

Lead Sponsor

Universitaire Ziekenhuizen KU Leuven

Age

0 - 0 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•CHD warranting a first percutaneous or surgical intervention in the first 6 months, including but not limited to transposition of the great arteries (TGA), univentricular heart (UVH), Tetralogy of Fallot (TOF), coarctation of the aorta (CoA), total abnormal pulmonary venous drainage (TAPVU), Common arterial trunc (TA), large patent ductus arteriosus (PDA) or VSD and AVSD for which treatment is necessary within the first 6 months of life.
•Treatment provided at the University Hospitals Leuven.

Exclusion Criteria

•Syndromes or proven genetic conditions which are associated with neurological impairment
•CHD warranting treatment after 6 months of life
•Suspected or proven metabolic diseases
•No parental/guardian consent

Related studies

Characterization of Social Cognition Profiles in Children and Adolescents With Neurodevelopmental Disorders: a Clinical Study Using a Multidimensional Battery

NCT07439276 · Neurodevelopmental Disorders, Autism Spectrum Disorder, and more

Fontan Fitness Trial

NCT06918795 · Single-ventricle, Congenital Heart Disease

RECRUITINGPhase 3

Reducing Missed Appointments

NCT06915480 · Neurodevelopmental Disorders

Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders

NCT07477197 · Adult Congenital Heart Disease, Pulmonary Hypertension, and more

RECRUITINGPhase 1

Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease

NCT05647213 · Univentricular Heart, Congenital Heart Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 2, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment200

Start dateDec 2023

Last updatedApr 2, 2025

Condition

Congenital Heart Disease Neurodevelopmental Disorders Electroencephalography Near-Infrared Spectroscopy Biomarkers

Locations shown

UZ Leuven

Leuven, Vlaams-Brabant

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 2, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions